Abstract
We report a case of Crohn’s disease associated with nephrotic syndrome due to renal amyloidosis in a 21-year-old man in whom remission of both Crohn’s disease and the nephrotic syndrome has been maintained with an elemental diet. The patient developed toxic megacolon and nephrotic syndrome due to renal amyloidosis. Intensive intravenous prednisolone therapy with total parenteral nutrition was dramatically effective in treating the toxic megacolon and inducing remission in Crohn’s disease and afterward, remission of the nephrotic syndrome. Remission of both conditions has been maintained for more than 2 years with the elemental diet. To our knowledge, this is the first confirmed case of Crohn’s disease complicated with renal amyloidosis in which only slight proteinuria (below 0.3 g/day) was shown with an elemental diet used for a long period.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Farmer RG, Hawk WA, Turnbull RB. Clinical patterns in Crohn’s disease: A statistical study of 615 cases. Gastroenterology 1975;68:627–635.
Grieco MB, Bordan DL, Geiss AC, et al. Toxic megacolon complicating Crohn’s colitis. Ann Surg 1980;191:75–80.
Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn’s disease and ulcerative colitis: A study of 700 patients. Medicine 1976;55:401–412.
Lowdell CP, Shousha S, Parkins RA. The incidence of amyloidosis complicating inflammatory bowel disease. A prospective survey of 177 patients. Dis Colon Rectum 1986;29:351–354.
Myren J, Bouchier IA, Watkinson G, et al. The OMGE multinational inflammatory bowel disease survey 1976–1982. A further report of 3175 cases. Scand J Gastroenterol 1988;23(Suppl 144):11–19.
Isobe Y, Chen ST, Nakane PK, et al. Studies on translocation of immunoglobulins across intestinal epithelium. I. Improvements in the peroxidase-labeled antibody methods for application to study of human intestinal mucosa. Acta Histochem Cytochem 1977;10:161–171.
Grant CS, Dozois RR. Toxic megacolon: Ultimate fate of patients after successful medical management. Am J Surg 1984;147:106–110.
Strauss RJ, Flint GW, Platt N, et al. The surgical management of toxic dilatation of the colon: A report of 28 cases and review of the literature. Ann Surg 1976;184:682–688.
Greenstein AJ, Sachar DB, Gibas A, et al. Outcome of toxic dilatation in ulcerative and Crohn’s colitis. J Clin Gastroenterol 1985;7:137–144.
Cunsolo A, Bragaglia RB, Arena N, et al. Toxic megacolon complicating ulcerative colitis and Crohn’s disease. Int Surg 1985;70:339–343.
Lind E, Fausa O, Gjone E, et al. Crohn’s disease. Treatment and outcome. Scand J Gastroenterol 1985;20:1014–1018.
Rashid H, Blake D, Gokal D, et al. The association of renal amyloidosis with regional enteritis (Crohn’s disease)—report of two cases and review of the literature. Clin Nephrol 1980;14:154–157.
Werther JL, Schapira A, Rubinstein O, et al. Amyloidosis in regional enteritis: Report of five cases. Am J Med 1960;29:416–423.
Mir-Madjlessi SH, Brown CH, Hawk WA. Amyloidosis associated with Crohn’s disease. Am J Gastroenterol 1972;58:563–577.
Fausa O, Nygaard K, Elgjo K. Amyloidosis and Crohn’s disease. Scand J Gastroenterol 1977;12:657–662.
Shorvon PJ. Amyloidosis and inflammatory bowel disease. Dig Dis Sci 1977;22:209–213.
Kahn E, Markowitz J, Simpser E, et al. Amyloidosis in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1989;8:447–453.
Fitchen JH. Amyloidosis and granulomatous ileocolitis. Regressionn after surgical removal of the involved bowel. N Engl J Med 1975;292:352–355.
Mandelstam P, Simmons DE, Mitchell B. Regression of amyloid in Crohn’s disease after bowel resection. A 19-year follow up. J Clin Gastroenterol 1989;11:324–326.
Verbanck J, Lameire N, Praet M, et al. Renal amyloidosis as complication of Crohn disease. Acta Clin Belg 1979;34:6–13.
Gries E, Singer MV, Goebell H. Amyloidosis in Crohn disease. Case reports and review of the literature. Med Klin 1989;84:65–71.
Schneider W, Martin P, Meinel K. Amyloidosis of the kidneys in Crohn’s disease. Z Gesamte Inn Med 1988;43:494–495.
Ravid M, Shapira J, Kedar I, et al. Regression of amyloidosis secondary to granulomatous ileitis following surgical resection and colchicine administration. Acta Hepatogastroenterol 1979; 26:513–515.
Maxwell MH, Adams DA, Goldman R. Cortisosteroid therapy of amyloid nephrotic syndrome. Ann Intern Med 1964;60:539–555.
Walser M, Hill S, Tomalis EA. Treatment of nephrotic adults with a supplemented, very low-protein diet. Am J Kidney Dis 1996;28:354–364.
O’Morain C, Segal AW, Levi AJ. Elemental diet as primary treatment of acute Crohn’s disease: A controlled trial. BMJ 1984;288:1859–1862.
Hirakawa H, Fukuda Y, Tanida N, et al. Home elemental enteral hyperalimentation (HEEH) for the maintenance of remission in patients with Crohn’s disease. Gastroenterol Jpn 1993;28:379–384.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Horie, Y., Chiba, M., Miura, K. et al. Crohn’s disease associated with renal amyloidosis successfully treated with an elemental diet. J Gastroenterol 32, 663–667 (1997). https://doi.org/10.1007/BF02934118
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02934118